Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine
Clinical trial NCT02453048 · COMPLETED
Trial details
- NCT number
- NCT02453048
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.